These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 30661824)
1. Synthesis, biological evaluation and mode of action studies of novel amidinourea inhibitors of hepatitis C virus (HCV). Magri A; Mokrane O; Lauder K; Patel AH; Castagnolo D Bioorg Med Chem Lett; 2019 Mar; 29(5):724-728. PubMed ID: 30661824 [TBL] [Abstract][Full Text] [Related]
2. Rethinking the old antiviral drug moroxydine: Discovery of novel analogues as anti-hepatitis C virus (HCV) agents. Magri A; Reilly R; Scalacci N; Radi M; Hunter M; Ripoll M; Patel AH; Castagnolo D Bioorg Med Chem Lett; 2015 Nov; 25(22):5372-6. PubMed ID: 26428870 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses. Toscani A; Denaro R; Pacheco SFC; Biolatti M; Anselmi S; Dell'Oste V; Castagnolo D Molecules; 2021 Aug; 26(16):. PubMed ID: 34443515 [TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel HCV replication inhibitors. McGowan DC; Khamlichi MD; De Groot A; Pauwels F; Delouvroy F; Van Emelen K; Simmen K; Raboisson P Mol Divers; 2017 May; 21(2):475-481. PubMed ID: 28293834 [TBL] [Abstract][Full Text] [Related]
5. Sequence-specific cleavage of hepatitis C virus RNA by DNAzymes: inhibition of viral RNA translation and replication. Roy S; Gupta N; Subramanian N; Mondal T; Banerjea AC; Das S J Gen Virol; 2008 Jul; 89(Pt 7):1579-1586. PubMed ID: 18559927 [TBL] [Abstract][Full Text] [Related]
6. Thiophen urea derivatives as a new class of hepatitis C virus entry inhibitors. Ryu HC; Windisch M; Lim JW; Choi I; Lee EK; Yoo HH; Kim TK J Enzyme Inhib Med Chem; 2021 Dec; 36(1):462-468. PubMed ID: 33455472 [TBL] [Abstract][Full Text] [Related]
7. A Novel Small Molecule Inhibits Hepatitis C Virus Propagation in Cell Culture. Oraby AK; Gardner CL; Needle RF; Kofahi HM; Everard KR; Taylor NGA; Rutihinda SG; Barry JP; Hirasawa K; Georghiou PE; Russell RS Microbiol Spectr; 2021 Sep; 9(1):e0043921. PubMed ID: 34319169 [TBL] [Abstract][Full Text] [Related]
8. In silico identification, design and synthesis of novel piperazine-based antiviral agents targeting the hepatitis C virus helicase. Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Courtney-Smith M; Brancale A Eur J Med Chem; 2017 Jan; 125():1115-1131. PubMed ID: 27810598 [TBL] [Abstract][Full Text] [Related]
9. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors. Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671 [TBL] [Abstract][Full Text] [Related]
10. Flavonoid-triazolyl hybrids as potential anti-hepatitis C virus agents: Synthesis and biological evaluation. Zhang H; Zheng X; Li J; Liu Q; Huang XX; Ding H; Suzuki R; Muramatsu M; Song SJ Eur J Med Chem; 2021 Jun; 218():113395. PubMed ID: 33838584 [TBL] [Abstract][Full Text] [Related]
11. The design, synthesis, and antiviral activity of 4'-azidocytidine analogues against hepatitis C virus replication: the discovery of 4'-azidoarabinocytidine. Smith DB; Kalayanov G; Sund C; Winqvist A; Pinho P; Maltseva T; Morisson V; Leveque V; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M J Med Chem; 2009 Jan; 52(1):219-23. PubMed ID: 19055482 [TBL] [Abstract][Full Text] [Related]
12. Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV. Bassetto M; Leyssen P; Neyts J; Yerukhimovich MM; Frick DN; Brancale A Bioorg Med Chem Lett; 2017 Feb; 27(4):936-940. PubMed ID: 28089348 [TBL] [Abstract][Full Text] [Related]
13. Synthesis of New Indanyl Nucleoside Analogues and their Biological Evaluation on Hepatitis C Virus (HCV) Replicon. Gómez ME; Gentile EA; Martini MF; Cuestas ML; Mathet VL; Moltrasio GY; Moglioni AG Molecules; 2019 Mar; 24(5):. PubMed ID: 30862130 [TBL] [Abstract][Full Text] [Related]
14. Cinnamic acid derivatives inhibit hepatitis C virus replication via the induction of oxidative stress. Amano R; Yamashita A; Kasai H; Hori T; Miyasato S; Saito S; Yokoe H; Takahashi K; Tanaka T; Otoguro T; Maekawa S; Enomoto N; Tsubuki M; Moriishi K Antiviral Res; 2017 Sep; 145():123-130. PubMed ID: 28780423 [TBL] [Abstract][Full Text] [Related]
15. High-Throughput Screening, Discovery, and Optimization To Develop a Benzofuran Class of Hepatitis C Virus Inhibitors. He S; Jain P; Lin B; Ferrer M; Hu Z; Southall N; Hu X; Zheng W; Neuenswander B; Cho CH; Chen Y; Worlikar SA; Aubé J; Larock RC; Schoenen FJ; Marugan JJ; Liang TJ; Frankowski KJ ACS Comb Sci; 2015 Oct; 17(10):641-52. PubMed ID: 26332742 [TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral evaluation of 7-O-arylmethylquercetin derivatives against SARS-associated coronavirus (SCV) and hepatitis C virus (HCV). Park HR; Yoon H; Kim MK; Lee SD; Chong Y Arch Pharm Res; 2012 Jan; 35(1):77-85. PubMed ID: 22297745 [TBL] [Abstract][Full Text] [Related]
17. Novel anilinocoumarin derivatives as agents against hepatitis C virus by the induction of IFN-mediated antiviral responses. Peng HK; Chen WC; Lee JC; Yang SY; Tzeng CC; Lin YT; Yang SC Org Biomol Chem; 2013 Mar; 11(11):1858-66. PubMed ID: 23377187 [TBL] [Abstract][Full Text] [Related]
18. The design, synthesis, and antiviral activity of monofluoro and difluoro analogues of 4'-azidocytidine against hepatitis C virus replication: the discovery of 4'-azido-2'-deoxy-2'-fluorocytidine and 4'-azido-2'-dideoxy-2',2'-difluorocytidine. Smith DB; Kalayanov G; Sund C; Winqvist A; Maltseva T; Leveque VJ; Rajyaguru S; Le Pogam S; Najera I; Benkestock K; Zhou XX; Kaiser AC; Maag H; Cammack N; Martin JA; Swallow S; Johansson NG; Klumpp K; Smith M J Med Chem; 2009 May; 52(9):2971-8. PubMed ID: 19341305 [TBL] [Abstract][Full Text] [Related]